FDA Approved: PEMRYDI RTU — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for PEMRYDI RTU, a ready-to-use formulation of pemetrexed disodium, developed by Amneal Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• PEMRYDI RTU (PEMETREXED DISODIUM)

Snippet

SUPPL AP for PEMRYDI RTU (PEMETREXED DISODIUM)